Anatara Lifesciences Ltd has released a press release.
3FDC Clinical Trial update
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Story so far
Earlier from Anatara Lifesciences
- Appendix 4E & Audited Financial Report 30 June 2022
- Operational Update
- Q4 FY22 Activities Report
- Quarterly Appendix 4C Cash Flow Report
- Clinical Trial and Operational Update
Later from Anatara Lifesciences
- Anatara Investor Presentation
- Entitlement Offer Prospectus
- Placement and Entitlement Offer
- Appendix 4C & Q1 FY23 Activities Report
- Completion of Non-renounceable Entitlement Offer and Shortfa
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences